about
In search of oral psoriasisUstekinumab in psoriasis immunopathology with emphasis on the Th17-IL23 axis: a primerPsoriasis and Atopic Dermatitis.Immunologic biomarkers for clinical and therapeutic management of psoriasis.New insights of T cells in the pathogenesis of psoriasisThe pathophysiological role of dendritic cell subsets in psoriasis.Genetic Epidemiology of PsoriasisIdentification of a novel proinflammatory human skin-homing Vγ9Vδ2 T cell subset with a potential role in psoriasis.Unusual case of B cell lymphoma after immunosuppressive treatment for psoriasisComparative genomic profiling of synovium versus skin lesions in psoriatic arthritis.Induction of GITRL expression in human keratinocytes by Th2 cytokines and TNF-α: implications for atopic dermatitis.Suppressive effect of β, β-dimethylacryloyl alkannin on activated dendritic cells in an imiquimod-induced psoriasis mouse model.The dark side of regulatory T cells in psoriasis2940-nm Er:YAG fractional laser enhanced the effect of topical drug for psoriasis.CCR6 is required for epidermal trafficking of γδ-T cells in an IL-23-induced model of psoriasiform dermatitisExpression of tumor necrosis factor alpha-induced protein 3 mRNA in peripheral blood mononuclear cells negatively correlates with disease severity in psoriasis vulgaris.Tissue-resident dendritic cells and diseases involving dendritic cell malfunctionMulti-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.Serum levels of selected Th17 and Th22 cytokines in psoriatic patients.Epidermal CD147 expression plays a key role in IL-22-induced psoriatic dermatitis.NK cells and psoriasis.Critical role of the interleukin-23/T-helper 17 cell axis in the pathogenesis of psoriasis.Current investigational drugs in psoriasis.Th22 and related cytokines in inflammatory and autoimmune diseases.Treatment of psoriasis and psoriatic arthritis.Emerging topical treatments for psoriasis.T-helper 22 cells as a new player in chronic inflammatory skin disorders.Impact of pregnancy and oestrogen on psoriasis and potential therapeutic use of selective oestrogen receptor modulators for psoriasis.Amentoflavone protects against psoriasis-like skin lesion through suppression of NF-κB-mediated inflammation and keratinocyte proliferation.Oxidative stress in psoriasis and potential therapeutic use of antioxidants.Regulation of proton-coupled folate transporter in retinal Müller cells by the antipsoriatic drug monomethylfumarate.Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from γδ-T cells.Psoriasiform skin disease in transgenic pigs with high-copy ectopic expression of human integrins α2 and β1A single intradermal injection of IFN-γ induces an inflammatory state in both non-lesional psoriatic and healthy skin.Interleukin-1 receptors are differentially expressed in normal and psoriatic T cellsHigh fat diet exacerbates murine psoriatic dermatitis by increasing the number of IL-17-producing γδ T cells.Behçet's disease in concurrence with psoriasis.Downregulation of PTEN expression in psoriatic lesions.Psoriasis and lasting implications.Expression of Th1 and Th2 Cytokine and Associated Transcription Factors in Peripheral Blood Mononuclear Cells and Correlation with Disease Severity.
P2860
Q22337450-2A5641A7-F26C-400D-89C7-7541DE8F22E7Q24596756-00001279-CD03-429F-8BB7-F54573A558E8Q30238648-2184BC52-A21F-4328-AAB1-D2F6DAEB1DB2Q34030644-6139ED04-24EE-48F2-88B4-DCA140458763Q34043846-72F9D5FF-1233-4EFB-BB97-9D49B7EE8332Q34180103-88F9BF91-0E9F-444C-8DDD-0A23E5DF4169Q34845927-2F710758-D3A6-40DD-9135-CF1E1E8AB67DQ35276090-263E7918-9386-40E9-BB64-5AA0C0A6D35EQ35501279-A87ED8BC-5350-42E4-BB98-442DE18F89A6Q35522947-0158F754-CF74-4DD0-B54F-2A0F74462822Q35835464-A3548F1A-BF49-499E-8828-F953FD45AE02Q35919093-C6BADFFC-7486-4BAB-83AF-A776169D4A2DQ36005466-601E7032-E788-4FA1-B711-308CEAC6A182Q36413794-2D5E8313-9F12-4AA3-96E9-AA8C971C5E8CQ36438118-7F1A1566-6028-4B4D-A798-458915A6C7AFQ36505184-9A2F77B6-6496-4B49-B8DC-7DBFCFA48812Q36759434-526C8C3A-E51F-4AE4-AA15-78D94E7305DDQ37187533-F20032CC-B338-4122-A185-34FDF9C8E68BQ37322356-97AF04C4-0C7F-492F-BEBD-9A6EF28E49FEQ37685970-9AD34F18-BFE9-4962-9B1E-A5753E626871Q37891799-EB876F4D-EDEF-4A28-B97F-FFAD6ABB4702Q37986832-596D4D91-8350-4D79-8AEE-51E7655AE1CFQ37991748-E7C47ECB-1DBB-40FE-A49F-A3A0619113EBQ38068964-AAB8795C-B6D7-4046-8057-190BE25A21A8Q38132706-8DE99144-EC41-4AD4-95D5-3164D06A2F0AQ38166017-8DDB2EB3-BDF4-44DC-810A-E16C03AE5C59Q38548745-A43A327E-E528-447F-8F2D-7125A6E275E2Q38807000-EAA28BCE-E8FB-4BED-B7B4-D3F09F7FED5AQ38807006-D827527B-EC0E-4DB9-9CFB-0DE42DC89C96Q38813221-106FC10B-8694-4AD3-BBEB-AB30677CEB65Q40642015-90A72357-E340-4FA6-B7B7-CD854DE0C22BQ40738483-2EBCD1AE-8FD4-4A2F-92BE-0B1523D50523Q41189572-FA2558DD-711E-45E7-BAB2-79A1C0082955Q41845458-6B7805CE-6C36-480A-B088-82CE7E9270D8Q41977448-F6107C64-E890-4CAA-8B73-2042DD569E2DQ42621252-D92135AE-0635-4A93-89EA-BADB913A9176Q44390640-F55435A2-DBDD-4D9B-BBCA-36DD39F5B4B7Q44801430-9A0D2998-6C7C-47C1-AD7C-90D756CAE207Q46138558-736C21FF-29F0-4FE2-955C-8745D23053CAQ47135666-A63E1776-BD74-4740-A585-BF592A9396C8
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
New insights in the immunologic basis of psoriasis.
@ast
New insights in the immunologic basis of psoriasis.
@en
type
label
New insights in the immunologic basis of psoriasis.
@ast
New insights in the immunologic basis of psoriasis.
@en
prefLabel
New insights in the immunologic basis of psoriasis.
@ast
New insights in the immunologic basis of psoriasis.
@en
P2093
P2860
P1476
New insights in the immunologic basis of psoriasis.
@en
P2093
Batya Davidovici
James G Krueger
Kristine E Nograles
P2860
P356
10.1016/J.SDER.2010.03.001
P577
2010-03-01T00:00:00Z